Randie Mclaughlin in Frederick, Maryland

Medical School: Sorry, her university is not listed
Graduation Year: 1991
The Primary Medical Specialty for Randie Mclaughlin is listed as: Nurse Practitioner
Approximate Years of Experience: 33
PAC (PECOS ID)#: 4587717921
NPI #: 1598756389
NPI Created On: 11/02/2005
NPI Last Updated Listed as: 07/30/2019
Primary Taxonomy Code: 363L00000X
License Number:
R072617
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• CareFirst BlueChoice, Inc.
• Group Hospitalization and Medical Services Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Bladder irrigation and/or instillation
2. Insertion of temporary bladder catheter
3. Insertion of indwelling bladder catheter
4. Bladder instillation of cancer preventive, inhibiting, or suppressive agent
5. Ultrasound measurement of bladder capacity after voiding
6. Automated urinalysis test
7. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
8. New patient office or other outpatient visit, typically 30 minutes
9. Established patient office or other outpatient visit, typically 10 minutes
10. Established patient office or other outpatient visit, typically 15 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes
13. Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes
14. Physician telephone patient service, 5-10 minutes of medical discussion
15. Physician telephone patient service, 11-20 minutes of medical discussion
16. Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic
17. Bcg live intravesical instillation, 1 mg
18. Leuprolide acetate (for depot suspension), 7.5 mg